PMID: 11920511Mar 29, 2002Paper

Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone

Cancer
Richard B WilderRaymond Alexanian

Abstract

Prognostic factors for solitary plasmacytoma of bone (SPB), whether measured before or after radiotherapy (RT), have not been established. The authors analyzed multiple factors for myeloma-free survival (MFS) and cause-specific survival (CSS) in SPB patients treated with RT alone. Between 1965 and 2000, 60 patients with carefully staged SPB were treated with RT alone at the M. D. Anderson Cancer Center. Patient ages ranged from 29-77 years (median, 54 years), and 75% of patients had a myeloma (M) protein in the blood and/or urine. No patients showed other lesions on skeletal survey or, in recent years, magnetic resonance imaging (MRI) of the spine; marrow aspirate was normal in all patients. Radiotherapy to the solitary lesion was given to a total dose of 30-70 Gy (median, 46 Gy). The authors analyzed the impact of multiple factors on MFS and CSS, including resolution v. persistence of M protein after RT, secretory v. nonsecretory disease at diagnosis, presence v. absence of an associated soft tissue mass on computed tomography or MRI scan, magnitude of serum M protein elevation at diagnosis, age, spinal v. nonspinal location, Karnofsky performance status, total RT dose, and tumor size. Median follow-up was 7.8 years (range, 1....Continue Reading

References

Jan 1, 1975·Archives of Internal Medicine·R Conklin, R Alexanian
Mar 15, 1992·Cancer·J HollandB Fineberg
Apr 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A DimopoulosR Alexanian
Feb 1, 1990·American Journal of Hematology·R AlexanianS Tucker
Apr 1, 1990·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·N A MayrA P Vigliotti
Jan 1, 1989·International Journal of Radiation Oncology, Biology, Physics·D A FrassicaR A Kyle
Nov 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L Y ChakR T Hoppe
Apr 1, 1995·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J J PavyH Bartelink
Sep 1, 1996·International Journal of Radiation Oncology, Biology, Physics·T W BolekN P Mendenhall
Aug 27, 1998·International Journal of Radiation Oncology, Biology, Physics·R H LiebrossR Alexanian
Jan 6, 2001·Acta Oncologica·M A DimopoulosR Alexanian
Apr 24, 2001·International Journal of Radiation Oncology, Biology, Physics·R W TsangA K Stewart

❮ Previous
Next ❯

Citations

Oct 4, 2002·Hematological Oncology
Feb 22, 2011·Annals of Hematology·Sonja KrauseDirk Neuhof
Apr 13, 2006·Clinical Rheumatology·Anna BlachEugene J Kucharz
Apr 6, 2004·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·L KochbatiM Maalej
Aug 5, 2006·Journal of Feline Medicine and Surgery·Paul J MellorMichael J Day
Nov 11, 2003·American Journal of Otolaryngology·William M MendenhallNancy Price Mendenhall
Jul 14, 2009·American Journal of Clinical Oncology·Roi DaganWilliam M Mendenhall
Jun 3, 2006·Blood·David DingliJerry A Katzmann
May 30, 2014·Der Radiologe·M C Schmaus, D Neuhof
Aug 31, 2013·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Nicolas H von der HoehChristoph-Eckhard Heyde
May 31, 2011·Critical Reviews in Oncology/hematology·Cyrus ChargariYoulia M Kirova
Jan 5, 2011·Revue neurologique·J LagardeA Ameri
Dec 1, 2010·Surgical Pathology Clinics·Robert B Lorsbach
Dec 10, 2008·The Orthopedic Clinics of North America·Narayan SundaresanStefano Boriani
Nov 29, 2008·International Journal of Radiation Oncology, Biology, Physics·Paul J KimMichael P Mac Manus
Apr 9, 2005·European Journal of Haematology·E JantunenT Nousiainen
Mar 11, 2004·British Journal of Haematology·Richard SoutarUNKNOWN British Society for Haematology
Aug 9, 2005·Pediatric Blood & Cancer·C DumesnilJ P Vannier
Oct 19, 2004·Clinical Oncology : a Journal of the Royal College of Radiologists·Richard SoutarUNKNOWN British Society for Haematology
Jul 28, 2004·La Revue de médecine interne·G EtienneM Longy-Boursier
Oct 19, 2005·International Journal of Radiation Oncology, Biology, Physics·Mahmut OzsahinAbderrahim Zouhair
Jul 5, 2005·Surgical Oncology·Kelly D NolanEdward W Nelson
May 29, 2015·Clinical Nuclear Medicine·Pierpaolo AlongiJamshed Bomanji
Jun 2, 2012·TheScientificWorldJournal·Sevil KilciksizAyfer Haydaroglu
Jan 1, 2014·Journal of Korean Neurosurgical Society·Jin Seo YangHyuk Jai Choi
Jun 16, 2006·Death Studies·Jennifer Clark, Majella Franzmann
Apr 21, 2017·The Neuroradiology Journal·Arian LasockiSimon J Harrison
Aug 22, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Domenico AlbanoFrancesco Bertagna
Feb 23, 2019·Current Hematologic Malignancy Reports·Andrew Pham, Anuj Mahindra
Nov 24, 2005·Hematology·Donna M Weber
Oct 24, 2002·Blood·Shaji KumarS Vincent Rajkumar
Sep 17, 2020·Clinical Medicine : Journal of the Royal College of Physicians of London·Charles AgbuduweThankamma Ajithkumar
Oct 6, 2020·Radiation Oncology Journal·Won Ick ChangIl Han Kim
Apr 19, 2018·Current Hematologic Malignancy Reports·Despina FotiouEfstathios Kastritis
Jan 15, 2020·The Pan African Medical Journal·Badr ElmorabitMouna Khouchani
Nov 28, 2019·Journal of Craniovertebral Junction and Spine·Suyash SinghSanjay Behari
Aug 13, 2020·International Journal of Hematology·Aya NakayaUNKNOWN Kansai Myeloma Forum Investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
R W TsangA K Stewart
International Journal of Radiation Oncology, Biology, Physics
R H LiebrossRaymond Alexanian
International Journal of Radiation Oncology, Biology, Physics
T W BolekN P Mendenhall
International Journal of Radiation Oncology, Biology, Physics
D A FrassicaR A Kyle
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
R H LiebrossRaymond Alexanian
© 2022 Meta ULC. All rights reserved